Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Social Meaning and the Unintended Consequences of Inclusion.

Creary M, Thiel D, Eisen A.

Am J Bioeth. 2017 Sep;17(9):63-65. doi: 10.1080/15265161.2017.1353180. No abstract available.

PMID:
28829254
2.

Perspectives and Practices of Athletic Trainers and Team Physicians Implementing the 2010 NCAA Sickle Cell Trait Screening Policy.

McDonald MA, Creary MS, Powell J, Daley LA, Baker C, Royal CD.

J Genet Couns. 2017 Dec;26(6):1292-1300. doi: 10.1007/s10897-017-0107-6. Epub 2017 Jun 3.

PMID:
28578465
3.

Biocultural citizenship and embodying exceptionalism: Biopolitics for sickle cell disease in Brazil.

Creary MS.

Soc Sci Med. 2018 Feb;199:123-131. doi: 10.1016/j.socscimed.2017.04.035. Epub 2017 Apr 26.

PMID:
28477966
4.

State-based surveillance for selected hemoglobinopathies.

Hulihan MM, Feuchtbaum L, Jordan L, Kirby RS, Snyder A, Young W, Greene Y, Telfair J, Wang Y, Cramer W, Werner EM, Kenney K, Creary M, Grant AM.

Genet Med. 2015 Feb;17(2):125-30. doi: 10.1038/gim.2014.81. Epub 2014 Jul 3.

5.

Use of the Word "Crisis" in Sickle Cell Disease: The Language of Sickle Cell.

Savitt TL, Smith WR, Haywood C, Creary MS.

J Natl Med Assoc. 2014 Summer;106(1):23-30. doi: 10.1016/S0027-9684(15)30067-5.

PMID:
26744112
6.

A study of prospective surveillance for inhibitors among persons with haemophilia in the United States.

Soucie JM, Miller CH, Kelly FM, Payne AB, Creary M, Bockenstedt PL, Kempton CL, Manco-Johnson MJ, Neff AT; Haemophilia Inhibitor Research Study Investigators.

Haemophilia. 2014 Mar;20(2):230-7. doi: 10.1111/hae.12302. Epub 2013 Nov 22.

7.

Acknowledging levels of racism in the definition of "difficult".

Creary M, Eisen A.

Am J Bioeth. 2013;13(4):16-8. doi: 10.1080/15265161.2013.767964. No abstract available.

PMID:
23514388
8.

Public health implications of sickle cell trait: a report of the CDC meeting.

Grant AM, Parker CS, Jordan LB, Hulihan MM, Creary MS, Lloyd-Puryear MA, Goldsmith JC, Atrash HK.

Am J Prev Med. 2011 Dec;41(6 Suppl 4):S435-9. doi: 10.1016/j.amepre.2011.09.012.

PMID:
22099370
9.

Sickle cell disease: the need for a public health agenda.

Yusuf HR, Lloyd-Puryear MA, Grant AM, Parker CS, Creary MS, Atrash HK.

Am J Prev Med. 2011 Dec;41(6 Suppl 4):S376-83. doi: 10.1016/j.amepre.2011.09.007.

PMID:
22099361
10.

F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race/ethnicity.

Miller CH, Benson J, Ellingsen D, Driggers J, Payne A, Kelly FM, Soucie JM, Craig Hooper W; Hemophilia Inhibitor Research Study Investigators.

Haemophilia. 2012 May;18(3):375-82. doi: 10.1111/j.1365-2516.2011.02700.x. Epub 2011 Nov 21.

PMID:
22103590
11.

A qualitative analysis of best self-management practices: sickle cell disease.

Tanabe P, Porter J, Creary M, Kirkwood E, Miller S, Ahmed-Williams E, Hassell K.

J Natl Med Assoc. 2010 Nov;102(11):1033-41.

PMID:
21141291
12.

Health status and healthcare use in a national sample of children with sickle cell disease.

Boulet SL, Yanni EA, Creary MS, Olney RS.

Am J Prev Med. 2010 Apr;38(4 Suppl):S528-35. doi: 10.1016/j.amepre.2010.01.003.

PMID:
20331954
13.

Sickle cell disease: current activities, public health implications, and future directions.

Creary M, Williamson D, Kulkarni R.

J Womens Health (Larchmt). 2007 Jun;16(5):575-82. Review.

PMID:
17627395
14.

Erythropoiesis and myocardial energy requirements contribute to the hypermetabolism of childhood sickle cell anemia.

Hibbert JM, Creary MS, Gee BE, Buchanan ID, Quarshie A, Hsu LL.

J Pediatr Gastroenterol Nutr. 2006 Nov;43(5):680-7.

15.

Proinflammatory cytokines and the hypermetabolism of children with sickle cell disease.

Hibbert JM, Hsu LL, Bhathena SJ, Irune I, Sarfo B, Creary MS, Gee BE, Mohamed AI, Buchanan ID, Al-Mahmoud A, Stiles JK.

Exp Biol Med (Maywood). 2005 Jan;230(1):68-74.

Supplemental Content

Loading ...
Support Center